<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03092622</url>
  </required_header>
  <id_info>
    <org_study_id>2013/2129</org_study_id>
    <nct_id>NCT03092622</nct_id>
  </id_info>
  <brief_title>Aerobic Interval Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Hypoxemia</brief_title>
  <official_title>Effects of Aerobic Interval Training on Cardiac Function, With Special Focus on Pulmonary Pressures and Right Sided Function, in Patients With Chronic Obstructive Pulmonary Disease and Hypoxemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with severe Chronic Obstructive Pulmonary Disease (COPD) and low oxygen levels in
      the blood are at risk of developing pulmonary hypertension and strain on the right side of
      the heart, both of which are known to increase symptoms and worsen prognosis It is not fully
      established whether interval exercise training in patients with severe COPD and concomitant
      low oxygen levels is beneficial.

      This study aims to evaluate the effects of aerobic interval exercise training in patients
      with severe COPD and low oxygen levels in the blood, with a particular emphasis on such
      effects on the cardiovascular system and pulmonary circulation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulmonary artery pressure</measure>
    <time_frame>Change from baseline at 10 weeks</time_frame>
    <description>Examined by right heart catheterisation</description>
  </primary_outcome>
  <other_outcome>
    <measure>Cardiac function</measure>
    <time_frame>Change from baseline at 10 weeks</time_frame>
    <description>assessed by echocardiography</description>
  </other_outcome>
  <other_outcome>
    <measure>Cardiac function</measure>
    <time_frame>Change from baseline at 10 weeks</time_frame>
    <description>assessed by right heart catheterisation</description>
  </other_outcome>
  <other_outcome>
    <measure>Respiratory function</measure>
    <time_frame>Change from baseline at 10 weeks</time_frame>
    <description>assessed by spirometry</description>
  </other_outcome>
  <other_outcome>
    <measure>Respiratory function</measure>
    <time_frame>Change from baseline at 10 weeks</time_frame>
    <description>assessed by diffusion capacity,</description>
  </other_outcome>
  <other_outcome>
    <measure>Respiratory function</measure>
    <time_frame>Change from baseline at 10 weeks</time_frame>
    <description>assessed by arterial blood gas</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional capacity</measure>
    <time_frame>Change from baseline at 10 weeks</time_frame>
    <description>assessed by shuttle walk test</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional capacity</measure>
    <time_frame>Change from baseline at 10 weeks</time_frame>
    <description>assessed by 6 minute walk test</description>
  </other_outcome>
  <other_outcome>
    <measure>Symptoms</measure>
    <time_frame>Change from baseline at 10 weeks</time_frame>
    <description>COPD Assessment Test (CAT)</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of life</measure>
    <time_frame>Change from baseline at 10 weeks</time_frame>
    <description>St George Respiratory Questionnaire (SGRQ)</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <condition>Hypertension, Pulmonary</condition>
  <condition>Hypoxia</condition>
  <arm_group>
    <arm_group_label>exercise training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Outpatients treadmill interval training, 4x4 minutes with 3 minutes in between at lower intensity. 3 sessions weekly for 10 weeks to a total of 30 sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Exercise training intervention as described earlier.</description>
    <arm_group_label>exercise training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic Obstructive Pulmonary Disease (COPD)

          -  Forced Expiratory Volume 1 second (FEV1) &lt;60% of predicted

          -  FEV1%FVC &lt;70 % of predicted (FVC = Forced Vital Capacity)

          -  Qualify for Long term oxygen therapy (LTOT), or presence of significant desaturation
             on exercise.

        Exclusion Criteria:

          -  Unstable ischaemic heart disease or valvular heart disease.

          -  Active malignant disease.

          -  Substance abuse.

          -  Physical or mental disability that prevents participation in the exercise programme or
             testing.

          -  Pregnancy.

          -  Exacerbation of COPD or respiratory tract infection last 6 weeks before.

          -  Completed pulmonary rehabilitation programme or other organised exercise programme
             last 3 month

          -  Use of high doses of systemic steroids.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Toril A Nagelhus Hernes, phd prof</last_name>
    <role>Study Chair</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sigurd Steinshamn, md prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lars Aakerøy</last_name>
    <phone>0047 72828140</phone>
    <email>lars.aakeroy@ntnu.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eivind Brønstad, phd</last_name>
    <email>eivind.bronstad@ntnu.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St Olavs Hospital, Lungemedisinsk Avdeling &amp; Hjertemedisinsk Avdeling</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Aakerøy, md</last_name>
      <email>lars.aakeroy@ntnu.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2017</study_first_submitted>
  <study_first_submitted_qc>March 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 28, 2017</study_first_posted>
  <last_update_submitted>April 27, 2018</last_update_submitted>
  <last_update_submitted_qc>April 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Exercise Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

